Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-21-003480
Filing Date
2021-11-08
Accepted
2021-11-08 16:24:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 eftr_pro_supp_q3_2021_10.htm 424B3 2460866
2 GRAPHIC img144408783_0.jpg GRAPHIC 32781
  Complete submission text file 0000950170-21-003480.txt   2507228
Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-259751 | Film No.: 211388327
SIC: 2834 Pharmaceutical Preparations